[{"Assets_0_Q1_USD":59293000.0,"CommonStockSharesOutstanding_0_Q1_shares":5007485.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-6859000.0,"NetIncomeLoss_1_Q1_USD":-10044000.0,"StockholdersEquity_0_Q1_USD":-38699000.0,"Ticker":"REPL","CIK":"1737953","name":"REPLIMUNE GROUP, INC.","OfficialName":"Replimune Group Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"857797433.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180830"}]